Clinical Trial Results:
A randomized, phase III, double blind, active-controlled, two-armed, multi-center study on efficacy and safety of once-daily oxcarbazepine (-modified release formulation) versus twice-daily oxcarbazepine (Timox®) in 300 patients with partial onset epilepsy
Summary
|
|
EudraCT number |
2004-002260-25 |
Trial protocol |
AT |
Global completion date |
01 Feb 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
18 Mar 2022
|
First version publication date |
18 Mar 2022
|
Other versions |
|
Summary report(s) |
OXC008K |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.